Citation Impact
Citing Papers
Immunoreactive substances of mycobacteria.
1982
Cutting Edge: Recognition of Gram-Positive Bacterial Cell Wall Components by the Innate Immune System Occurs Via Toll-Like Receptor 2
1999 Standout
Nutrition and Infectious Diseases in Developing Countries and Problems of Acquired Immunodeficiency Syndrome
2004
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2
2003 Standout
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
2003 Standout
The evolving role of natural products in drug discovery
2005 Standout
[20] Isolation of peptidoglycan and soluble peptidoglycan fragments
1994
Bacteriocins: developing innate immunity for food
2005 Standout
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Zinc and immune function: the biological basis of altered resistance to infection
1998
Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
1999 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
The Bacterial Cell Envelope
2010 Standout
Effects of Moenomycin on Escherichia coli
1987
Adjuvants—a classification and review of their modes of action
1997
New horizons in adjuvants for vaccine development
2020
Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation
2005
Growth Hormone-Releasing Activity of Thymulin on Pituitary Somatotropes Is Age Dependent
1999
The Science of Antibiotic Discovery
2020 Standout
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
1995
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
The Lantibiotic Mersacidin Inhibits Peptidoglycan Biosynthesis at the Level of Transglycosylation
1997
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
CD36 is a sensor of diacylglycerides
2005 StandoutNatureNobel
The biofilm matrix
2010 Standout
New horizons in adjuvants for vaccine development
2008
The murein hydrolases of Escherichia coli: properties, functions and impact on the course of infections in vivo
1991
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Probing Teichoic Acid Genetics with Bioactive Molecules Reveals New Interactions among Diverse Processes in Bacterial Cell Wall Biogenesis
2009
Where and why are 10 million children dying every year?
2003 Standout
Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59
1995
Mechanisms of Antimicrobial Peptide Action and Resistance
2003 Standout
Perturbations of both nonregulatory and regulatory FOXP3+ T cells in patients with malignant melanoma
2010 StandoutNobel
Interleukin-1-induced sleep and febrile responses differentially altered by a muramyl dipeptide derivative
1989
Emergence of vancomycin tolerance in Streptococcus pneumoniae
1999 StandoutNatureNobel
What works? Interventions for maternal and child undernutrition and survival
2008 Standout
Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions
2004 Standout
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
2008
Biosynthesis of emulsan biopolymers from agro-based feedstocks
2006
Zinc, thymic endocrine activity and mitogen responsiveness (PHA) in piglets exposed to maternal aflatoxicosis B1 and G1
1998
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
How antibiotics kill bacteria: from targets to networks
2010 Standout
Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative
1982
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
1991 StandoutNobel
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.
1980
Peptide Antimicrobial Agents
2006 Standout
Rhodococcus equi: an animal and human pathogen
1991 Standout
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
High-Throughput Screen for Inhibitors of Transglycosylase and/or Transpeptidase Activities of Escherichia coli Penicillin Binding Protein 1b
2003
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Analysis of Peptidoglycan Structure from Vegetative Cells of Bacillus subtilis 168 and Role of PBP 5 in Peptidoglycan Maturation
1999
Analysis of murein and murein precursors during antibiotic-induced lysis of Escherichia coli
1991
The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II
1998
Selection of a muramyl peptide based on its lack of activation of nuclear factor-κB as a potential adjuvant for AIDS vaccines
1992
Ribosomal Synthesis of Dehydroalanine-Containing Peptides
2006 StandoutNobel
Three Decades of β-Lactamase Inhibitors
2010 Standout
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
1999 Science
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
1986 StandoutNobel
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 StandoutNobel
The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
1993
TRACP Influences Th1 Pathways by Affecting Dendritic Cell Function
2006 StandoutNobel
Mechanism of Action of the Mannopeptimycins, a Novel Class of Glycopeptide Antibiotics Active against Vancomycin-Resistant Gram-Positive Bacteria
2004
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria
2003 Standout
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
Adjuvant activity of chitin derivatives in mice and guinea-pigs
1985
Morphogenesis of Escherichia coli
1998
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
1999 Science
Impact of Flavophospholipol and Vancomycin on Conjugational Transfer of Vancomycin Resistance Plasmids
2000
Biosynthesis and Mode of Action of Lantibiotics
2005
Die charakteristische AT‐III‐Bindungsregion in Heparin: eine Leitstruktur für neue synthetische Antithrombotica
1993
Stimulation of cytokine production in mice using deacetylated chitin
1986
An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity
1986
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
2003
Muramyl Peptides as Possible Endogenous Immunopharmacological Mediators
1983
Distinct Constrictive Processes, Separated in Time and Space, DivideCaulobacterInner and Outer Membranes
2005 StandoutNobel
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
2003 Standout
Mutational Analysis of theStreptococcus pneumoniaeBimodular Class A Penicillin-Binding Proteins
1999
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Prediction of protein antigenic determinants from amino acid sequences.
1981 Standout
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of M. Derrien being referenced
Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides
1982
Contribution of zinc and other metals to the biological activity of the serum thymic factor.
1982
Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3
1992
Polymerization by transglycosylation in the biosynthesis of the peptidoglycan of Escherichia coli K 12 and its inhibition by antibiotics
1978
A new, highly potent, heparin-like pentasaccharide fragment containing a glucose residue instead of a glucosamine
1991
SYNTHESIS OF SOME NEW ANALOGS OF THE IMMUNOADJUVANT GLYCOPEPTIDE MDP (N‐ACETYL‐MURAMYL‐L‐ALANYL‐D‐ISOGLUTAMINE)
1978
Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue
1980
SYNTHESIS OF N‐ACETYL‐MURAMYL‐l‐ALANYL‐d‐GLUTAMIC‐α‐AMIDE(MDP) OR ‐α‐METHYL ESTER DERIVATIVES, BEARING A LIPOPHILIC GROUP AT THE C‐TERMINAL PEPTIDE END
1979
SYNTHESIS OF N‐ACETYL‐MURAMYL‐L‐ALANYL‐D‐ISOGLUTAMINE, AN ADJUVANT OF THE IMMUNE RESPONSE, AND OF SOME N‐ACETYL‐MURAMYL‐PEPTIDE ANALOGS
1977